MedTrace Logo

Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2

NCT03586258 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-04-13

No results posted yet for this study

Summary

Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative/developmental disorders and selective cognitive disorders; (ii) healthy control subjects.

The objective of this project is to evaluate specific neuropsychological deficits and apply current brain imaging techniques (anatomical, diffusion, functional, magnetic stimulation) to patients suffering from these cognitive deficits due to brain damage, in order to elucidate the brain mechanisms underlying these deficits.

Conditions

  • Cerebrovascular Disorders
  • Brain Lesion
  • Degenerative Disease
  • Developmental Disability

Interventions

BEHAVIORAL

Neuropsychological testing

Experimental test about cognitive deficit of interest and standard neuropsychological tests

OTHER

Brain Imaging

Anatomical, diffusion, and/or functional MRI

OTHER

Galvanic Vestibular Stimulation (GVS)

Stimulation versus Sham

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Olivier MARTINAUD, MD, PhD · Caen University Hospital, Normandie UNIV, UNICAEN, PSL Research University, EPHE, Inserm, U1077, CHU de Caen, Neuropsychologie et Imagerie de la Mémoire Humaine, 14000 Caen, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2028-06-30
Completion
2030-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586258 on ClinicalTrials.gov